Retinal Probe Market Global Report 2026

The retinal probe market size has grown rapidly in recent years. It will grow from $0.92 billion in 2025 to $1.02 billion in 2026 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing prevalence of diabetic retinopathy, rising incidence of retinal detachment disorders, growth in vitreoretinal surgical volumes, advancements in ophthalmic microsurgery techniques, expanding access to specialized eye care services.

The retinal probe market size is expected to see rapid growth in the next few years. It will grow to $1.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to growing demand for minimally invasive retinal interventions, increasing adoption of microincision vitreoretomy systems, rising aging population with retinal disorders, expanding investments in ophthalmic surgical technologies, growing number of retina specialty treatment centers. Major trends in the forecast period include growing adoption of ultra thin microincision retinal probes for minimally invasive procedures, increasing demand for disposable retinal probes to improve surgical sterility, rising utilization of high gauge retinal probes for enhanced surgical precision, expanding use of multifunctional retinal probes in complex vitreoretinal procedures, increasing integration of advanced fiber optic illumination in retinal surgeries.

The increasing prevalence of retinal disorders is anticipated to drive the growth of the retinal probe market in the coming years. Retinal disorders are conditions that affect the retina, such as diabetic retinopathy, retinal detachment, and age-related macular degeneration, which may lead to significant vision loss or blindness if not detected and managed at an early stage. The growing prevalence of retinal disorders is attributed to the rising diabetic population and the expanding elderly population, which is more vulnerable to chronic eye-related conditions. Retinal probe procedures aid in retinal disease management by facilitating precise retinal imaging, minimally invasive vitreoretinal surgical procedures, laser-based treatment applications, and therapeutic monitoring, thereby enhancing surgical accuracy and improving patient outcomes. For instance, in July 2025, according to the Welsh Government, a UK-based government administration organization, more than 197,000 individuals were eligible for diabetic eye screening as of March 2025, reflecting a 1.7% rise compared with the previous year, while 34.1% of more than 88,000 completed screening appointments detected some level of diabetic retinopathy. Therefore, the growing prevalence of retinal disorders is contributing to the expansion of the retinal probe market.

Major companies operating in the retinal probe market are concentrating on the development of advanced solutions, such as next-generation vitreoretinal surgical platforms featuring ultra-high cut rate probes, intelligent fluidics, and integrated cataract-retinal surgery capabilities, to enhance surgical efficiency, procedural accuracy, and patient outcomes in ophthalmic procedures. High-speed vitrectomy probe systems are advanced surgical devices designed with improved cutting speeds, optimized fluid management systems, and integrated platform capabilities that allow surgeons to perform complex retinal procedures with enhanced precision, control, and efficiency. For example, in April 2025, Alcon, a Switzerland-based ophthalmic medical technology company, launched the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS). The platform incorporates the HYPERVIT 30K, recognized as the world’s fastest vitrectomy probe with 30,000 cuts per minute, along with UNITY Intelligent Fluidics and UNITY 4D Phaco technologies. The system is designed to support vitreoretinal and cataract procedures by enabling surgeons to operate under more physiologically optimized conditions while improving efficiency, precision, and workflow effectiveness during minimally invasive retinal surgeries. Therefore, technological advancements in high-speed retinal probe systems are contributing to the expansion of the retinal probe market.

In April 2024, Carl Zeiss Meditec AG, a Germany-based provider of ophthalmic diagnostic systems, acquired Dutch Ophthalmic Research Center (D.O.R.C. International B.V.) for $1.1 billion. Through this acquisition, ZEISS aimed to strengthen and expand its ophthalmic surgical portfolio, improve digitally integrated retinal surgery workflows, and enhance its presence in the vitreoretinal surgical devices and consumables market through advanced ophthalmic technologies and comprehensive surgical solutions. Dutch Ophthalmic Research Center (D.O.R.C. International B.V.) is a Netherlands-based provider of vitreoretinal surgical systems, retinal probes, ophthalmic surgical instruments, surgical liquids, consumables, fluid management systems, and EVA NEXUS retinal surgery platforms for ophthalmic and cataract procedures.

Major companies operating in the retinal probe market report are Alcon Inc., Bausch & Lomb Incorporated, Appasamy Associates Private Limited, Lumibird Medical Group, BVI Medical Inc., Iridex Corporation, Keeler Limited, Duckworth & Kent Limited, Geuder AG, Advin Health Care, Akriti Ophthalmic Private Limited, Basco India, Beye LLC, FCI S.A.S., Ophtho India Private Limited, Vortex Surgical Inc., RUMEX Baltics SIA, Carl Zeiss Meditec AG, Avanos Medical Inc., Optikon, Sterimed Medical Devices Pvt. Ltd.

North America was the dominating region in the retinal probe market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the retinal probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the retinal probe market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.